Status
Conditions
Treatments
About
The primary objective of this clinical study was to show that tonometry values for TONOREF III, as the representative device of the NIDEK tonometer series, were comparable to the predicate device.
The secondary objective was to demonstrate that the test device was as safe as the predicate device.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Each subject had to have:
Exclusion criteria
Each subject had to not to :
Primary purpose
Allocation
Interventional model
Masking
52 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal